| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 2113650-04-5 | (R)-2-((2-((3-氰基苄基)氧基)-4-((3-(2,3-二氢苯并[b][1,4]二氧杂环己烯-6-基)-2-甲基苄基) 氧基)-5-甲基苄基)氨基)-3-羟基丙酸盐酸盐
(2-((3-Cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)-5-methylbenzyl)-D-serine hydrochloride | |
C35H35ClN2O7 | 631.11 |
| 1323077-89-9 | (R)-1-(3-甲基异恶唑-4-羰基)-10a-(6-甲基吡啶-3-基)-2,3,10,10a-四氢咪唑并[1,2-a]吡咯并[1,2-d]吡嗪-5(1H)-酮
(R)-1-(3-Methylisoxazole-4-carbonyl)-10a-(6-methylpyridin-3-yl)-2,3,10,10a-tetrahydroimidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5(1H)-one | |
C20H19N5O3 | 377.40 |
| 220556-74-1 | (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide
| |
C21H39NO2 | 337.5 |
| 98791-67-4 | (R)-(+)-Bay-K-8644
| |
C16H15F3N2O4 | 356.30 |
| 1217757-71-5 | (R)-(+)-5'-Hydroxyphenyl Carvedilol
| |
C24H26N2O5 | 422.47 |
| 2227246-92-4 | (Fmoc-氨基)-PEG12-C2-羧酸NHS酯
2,5-Dioxopyrrolidin-1-yl 1-(9H-fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxa-4-azatritetracontan-43-oate | |
C46H68N2O18 | 937.03 |
| 137089-36-2 | (E)-N-[2-(2-cyclohexylethylsulfanyl)ethyl]dec-2-enamide
2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide | |
C20H37NOS | 339.58 |
| 1375060-02-8 | (E)-N'-(4-(二乙基氨基)-2-羟基亚苄基)烟酰肼
(E)-N'-(4-(Diethylamino)-2-hydroxybenzylidene)nicotinohydrazide | 密度：1.16±0.1 g/cm3(Predicted)
|
C17H20N4O2 | 312.37 |
| 933030-60-5 | (E)-C-HDMAPP (ammonium salt)
(E)-C-HDMAPP (ammonium salt) ((E)-5-hydroxy-4-methylpent-3-enyl pyrophosphate) | |
C6H14O7P2 • 3NH4 | 311.2 |
| 125720-84-5 | (E)-Alprenoxime
| |
C15H22N2O2 | 262.35 |
| 959841-49-7 | (E)-AKTIV
(E)-Akt inhibitor-IV | |
C31H27IN4S | 614.54 |
| 1255639-43-0 | (E)-5-(4-羟基苯基)-2-((E)-3-(4-羟基苯基)丙烯酰基)-3-氧代-N-苯基戊-4-烯酰胺
(E)-5-(4-hydroxyphenyl)-2-((E)-3-(4-hydroxyphenyl)acryloyl)-3-oxo-N-phenylpent-4-enamide | |
C26H21NO5 | 427.5 |
| 58436-29-6 | (E)-3-甲氧基-5-(4-甲氧基苯乙烯基)苯酚
(E)-3-Methoxy-5-(4-methoxystyryl)phenol | |
C16H16O3 | 256.3 |
| 1198078-60-2 | (E)-3-(2-Bromo-3,4-dihydroxyphenyl)-N-(3,4,5-trihydroxybenzyl)prop-2-enethioamide
| |
C16H14BrNO5S | 412.26 |
| 1245792-51-1 | (E)-2-亚苄基-3-(环己基氨基)-2,3-二氢-1H-茚-1-酮
(E)-2-Benzylidene-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one | |
C22H23NO | 317.42 |
| 22644-96-8 | (E)-2-Hexadecenal
(E)-2-Hexadecenal (trans-2-Hexadecenal) | |
C16H30O | 238.4 |
| 133550-22-8 | (E)-2-benzoyl-3-(3,4-dihydroxyphenyl)prop-2-enenitrile
EGFR-IN-16 | |
C16H11NO3 | 265.26 |
| 51589-67-4 | (E)-1-(5-羟基-2,2-二甲基-2H-苯并吡喃-6-基)-3-(4-甲氧基苯基)丙-2-烯-1-酮
4-Methoxylonchocarpin | 密度：1.193±0.06 g/cm3(Predicted)
沸点：535.2±50.0 °C(Predicted)
|
C21H20O4 | 336.38 |
| 134271-74-2 | (E)-1-(2-aminophenyl)-3-(3-nitrophenyl)prop-2-en-1-one
CDC25B-IN-2 | |
C15H12N2O3 | 268.27 |
| 1217759-04-0 | (9H-芴-9-基)甲氧基]羰基D-2-氨基甲酰基
Fmoc-D-2-carbamoylphenylalanine | |
| |
| 868774-16-7 | (6S)-N-苄基-6-(4-羟基苄基-6-(4-萘-1-基甲基-6-(4-二氧代六氢-2H-吡嗪并[1,2-a]嘧啶-1(6H)-甲酰胺
(6S)-N-Benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxohexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide | 密度：1.37±0.1 g/cm3(Predicted)
沸点：895.6±65.0 °C(Predicted)
|
C33H32N4O4 | 548.63 |
| 2828432-48-8 | (6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-12,29-双(3-氨基丙基)-6,23-二苄基-9,26-二异丁基-15,32-二异丙基二十四氢二吡咯烷并[1,2-a:1',2'-p][1,4,7,10,13,16,19,22,25,28]十氮杂环三十烷-5,8,11,14,17,22,25,28,31,34-十酮三氟乙酸盐
(6R,9S,12S,15S,17aS,23R,26S,29S,32S,34aS)-12,29-Bis(3-aminopropyl)-6,23-dibenzyl-9,26-diisobutyl-15,32-diisopropyltetracosahydrodipyrrolo[1,2-a:1',2'-p][1,4,7,10,13,16,19,22,25,28]decaazacyclotriacontine-5,8,11,14,17,22,25,28,31,34-decaone trifluoroacetat | |
C62H93F3N12O12 | 1255.47 |
| 1361390-56-8 | (5S,8S,E)-2,5-二氧代吡咯烷-1-基 11-(2-氨基-2-氧代乙基)-5,8-二甲基-3,6,9,12-四氧代-1-苯基-2-氧杂-4,7,10,11-四氮杂pentadec-13-烯-15-酸酯
(5S,8S,E)-2,5-Dioxopyrrolidin-1-yl 11-(2-amino-2-oxoethyl)-5,8-dimethyl-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadec-13-en-15-oate | |
C24H28N6O10 | 560.51 |
| 210344-96-0 | (5S,8S,11S,14S)-11-((S)-仲丁基)-14-(2-氟乙酰基)-5-异丙基-8-(3-甲氧基-3-氧代丙基)-3,6,9,12-四氧代-1-苯基-2-氧杂-4,7,10,13-四氮杂十六烷-16-酸甲酯
Methyl (5S,8S,11S,14S)-11-((S)-sec-butyl)-14-(2-fluoroacetyl)-5-isopropyl-8-(3-methoxy-3-oxopropyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13-tetraazahexadecan-16-oate | |
C31H45FN4O10 | 652.71 |
| 173388-20-0 | (5S)-5-[(2R)-2-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]propyl]-3-methylideneoxolan-2-one
TEI-9647 | |
C27H38O4 | 426.59 |
| 180916-16-9 | (5R,6S)-6-苯基-5-(4-(2-(吡咯烷-1-基)乙氧基)苯基)-5,6,7,8-四氢萘-2-醇
(5R,6S)-6-Phenyl-5-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,6,7,8-tetrahydronaphthalen-2-ol | 密度：1.150±0.06 g/cm3(Predicted)
熔点：110-113 °C
沸点：572.4±50.0 °C(Predicted)
|
C28H31NO2 | 413.55 |
| 189013-61-4 | (5R)-BW-4030W92
| |
C11H9Cl2FN4 | 287.12 |
| 593273-05-3 | (5E)-1-(3-chloro-4-methylphenyl)-5-[(2E)-3-(furan-2-yl)prop-2-en-1-ylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
DCH36_06 | |
C18H13ClN2O3S | 372.83 |
| 349536-41-0 | (5-氯-3-(4-(甲基磺酰基)苯基)-[2,3'-联吡啶]-6'-基)甲醇(依托考昔杂质)
6′-Desmethyl-6′-methylhydroxy Etoricoxib | |
| |
| 870603-16-0 | (5-(2-(5-氯-2-甲基苯基)-1-羟基-3-氧代异吲哚啉-1-基)-1H-苯并[d]咪唑-2-基)氨基甲酸甲酯
Methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxoisoindolin-1-yl)-1H-benzo[d]imidazol-2-yl)carbamate | |
C24H19ClN4O4 | 462.89 |
| 1237168-58-9 | (5-((2-((4-氟-3-甲氧基-5-甲基苯基)氨基)-5-甲基嘧啶-4-基)氨基)-2-氧代苯并[d]恶唑-3(2H)-基)甲基磷酸酯
(5-((2-((4-Fluoro-3-methoxy-5-methylphenyl)amino)-5-methylpyrimidin-4-yl)amino)-2-oxobenzo[d]oxazol-3(2H)-yl)methyl dihydrogen phosphate | 密度：1.564±0.06 g/cm3(Predicted)
沸点：761.3±70.0 °C(Predicted)
|
C21H21FN5O7P | 505.39 |
| 357336-19-7 | (4S)-布瓦西坦
(4S)-Brivaracetam | |
C11H20N2O2 | 212.29 |
| 1897428-40-8 | (4S)-2,2,4-Trimethylpyrrolidine Hydrochloride
| |
C7H15N • HCl | 113.20 |
| 2828432-43-3 | (4R,7S,10S,13R,16S,19R)-13-((1H-吲哚-3-基)甲基)-N-((2S,3R)-1-氨基-3-羟基-1-氧代丁烷- 2-基)-19-((R)-2-氨基-3-苯基丙酰胺基)-10-(3-氨基丙基)-16-(4-羟基苄基)-7-((R)-1-羟乙基)-3,3-二甲基-6,9,12,15,18-五氧代-1,1,2-二硫杂-5,8,11,14,17-五氮杂环二十烷-4-羧酰胺三氟乙酸盐
CTOP trifluoroacetate | |
C52H68F3N11O13S2 | 1176.29 |
| 222318-55-0 | (4E)-SUN9221
| |
C25H31FN4O3 | 454.54 |
| 511514-03-7 | (4-phenyl-quinazolin-2-yl)-(4,6,6-trimethyl-1,6-dihydro-pyrimidin-2-yl)-amine
0990CL | |
C21H21N5 | 343.42 |
| 1016543-77-3 | (4-(2-aminothiazol-4-yl)-2-(1h-1,2,4-triazol-1-yl)phenyl)(3,4,5-trimethoxyphenyl)methanone
| |
C21H19N5O4S | 437.47 |
| 53495-21-9 | (3β,20E)-24-Norchola-5,20(22)-diene-3,23-diol
| |
C23H36O2 | 344.53 |
| 65454-13-9 | (3S,6R)-Lateritin
| |
C15H19NO3 | 261.31 |
| 1428118-38-0 | (3S,5S)-Atorvastatin sodium salt
| |
C33H34FN2O5 • Na | 580.6 |
| 1801765-04-7 | (3S,4S)-8-(6-氨基-5-((2-氨基-3-氯吡啶基-4-基)硫代)吡嗪-2-基)-3-甲基-2-氧杂-8-氮杂螺[4.5]癸-4-胺
(3S,4S)-8-(6-Amino-5-((2-amino-3-chloropyridin-4-yl)sulfanyl)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro( 4.5)decan-4-amine | |
C18H24ClN7OS | 421.950 |
| 919514-01-5 | (3S)-3-(2,3,4,5,6,7,8-heptadeuterionaphthalen-1-yl)oxy-N-methyl-3-thiophen-2-ylpropan-1-amine
Duloxetine-d7 | |
C18H12D7NOS | 304.46 |
| 60761-51-5 | (3R)-hydroxy Quinidine
(3R)-hydroxy Quinidine (3-epi-hydroxy Quinidine) | |
C20H24N2O3 | 340.4 |
| 230961-21-4 | (3R)-3-[[(2S)-1-[[(1S)-2-Methoxy-1-phenylethyl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamoyl]-6-(3-methyl-4-phenylphenyl)hexanoic acid
UK-370106 | |
C35H44N2O5 | 572.73 |
| 1346600-05-2 | (3aS,7aS)-3a-(3,4-dimethoxyphenyl)-1-(trideuteriomethyl)-2,3,4,5,7,7a-hexahydroindol-6-one
Mesembrine-d3 | |
C17H20D3NO3 | 292.39 |
| 2218463-36-4 | (35-羟基-3,6,9,12,15,18,21,24,27,30,33-十一氧杂三十五烷基)氨基甲酸叔丁酯
tert-Butyl (35-hydroxy-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontyl)carbamate | |
C29H59NO14 | 645.78 |
| 900314-03-6 | (3-Methyl-4-(m-tolyl)piperazin-1-yl)(7-methylthieno[2,3-b]quinolin-2-yl)methanone
| |
C25H25N3OS | 415.55 |
| 528893-52-9 | (2Z)-3-[5-(2-Amino-5-chlorophenyl)-1H-1,2,4-triazol-1-yl]-2-propenoic acid ethyl ester
PKF050-638 | |
C13H13ClN4O2 | 292.72 |
| 1378391-45-7 | (2S,4S)-2-[5-[1,11-二氢-2-[(2S,5S)-1-[(2S)-2-[(甲氧羰基)氨基]-3-甲基-1-氧代丁基]-5-甲基-2-吡咯烷基][2]苯并吡喃并[4',3':6,7]萘并[1,2-D]咪唑-9-基]-1H-咪唑-2-基]-4-(甲氧基甲基)-1-吡咯烷羧酸叔丁酯
(2S,4S)-tert-Butyl 2-(5-(2-((2S,5S)-1-((S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidine-1-carboxylate | |
C44H53N7O7 | 791.93 |
| 7196-71-6 | (2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基 3-(4-羟基-3-甲氧基苯基)丙烯酸酯
Ferulic acid acyl-β-D-glucoside | |
C16H20O9 | 356.32 |
